Clinical Trials
21 trialsBIChE-1
University Hospital, Angers
MRI in High-Grade Glioma Patients Undergoing Chemoradiation
Wake Forest University Health Sciences
Andro-iGlio
Assistance Publique - Hôpitaux de Paris
IMMUNEORGANOID
Gustave Roussy, Cancer Campus, Grand Paris
BIOLIMEN-1
University Hospital, Montpellier
MM-Predict
Assistance Publique Hopitaux De Marseille
EPIGLIO
Institut du Cancer de Montpellier - Val d'Aurelle
GLIOMIT
Centre Hospitalier Universitaire, Amiens
GLIOLIPSY
University Hospital, Montpellier
ALCINA2
Institut du Cancer de Montpellier - Val d'Aurelle
BOOSTCAR
Central Hospital, Nancy, France
ExoGLIE
University Hospital, Limoges
PHRCNB07
Institut Curie
FKBP51s: a New Molecular Biomarker for Glioblastoma? Pre- and Post-operative Blood Levels Evaluation of FKBP51s Protein and Correlation With MRI Phenotype
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Explor-AVD
Hopital Foch
PLANET
Centre Leon Berard
ONCOPRO
Hospices Civils de Lyon
Treatment Effects Inclusive Cognitive Impact and Possibilities to Individually Adjusted Treatment in Patients With Intracranial Tumors With Clinical, Neuropsychological and Imaging Parameters
Lund University Hospital
89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme
Memorial Sloan Kettering Cancer Center
Prospective Evaluation of T-cell Immune Status in Patients With Newly Diagnosed High Grade Gliomas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Tumor DNA and MRI/CT Scan Findings in Patients With Grade III or Grade IV Malignant Glioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins